透過您的圖書館登入
IP:3.129.249.117
  • 期刊
  • OpenAccess

Interventional Cardiac Catheterization for Structural Cardiovascular Defects: The State of the Art in Taiwan

介入性心導管術治療結構性心臟血管畸形異常:在台灣的發展及現況

摘要


自從1966年Rashkind及Miller醫師首創以球囊導管,完成心房中膈造口術,姑息治療大動脈轉位病嬰後,介入性心導管術已發展40餘年。由於許多新的醫療儀器開發,球囊導管、支架、各種封堵器的研發及心臟血管影像學的進步,使許多先天性及結構性心臟血管的畸形異常,都可經不剖開胸腔及(或)不剖開心臟手術而治(療)癒。介入性心導管擴張術及關閉術都是在全身或局部麻醉或鎮靜劑的協助下,經皮穿刺,由腹股溝處動靜脈,將導管、支架、或各種封堵器置入,就可完成手術。本篇是介紹在台灣,這種介入性心導管術治療結構性心血管缺損的發展及目前現況。

並列摘要


Since the introduction of balloon atrial septostomy by Rashkind and Miller in 1966, interventional cardiac catheterization has been developed for more than 40 years. With the development of new medical equipment, balloon catheters, stents, various occlusion devices, and the advancing imaging modalities, many congenital and acquired structural anomalies of cardiovascular system can be successfully treated without open chest and/or heart. Basic techniques including dilatation and occlusion are performed percutaneously from the peripheral vessels of inguinal regions under general or local anesthesia with sedation. This article reviews the developing skills and current techniques for treatment of structural cardiovascular defects in Taiwan.

延伸閱讀